Antech, Royal Canin share supporting kidney health with cat food - Pet Food Processing

LAS VEGAS — Antech Diagnostics and Royal Canin introduced a new preventative nutritional solution to help pet owners address renal problems in cats on Sept. 7 to complement RenalTechTM, an innovative diagnostic tool that may anticipate feline chronic kidney disease (CKD) up to two years before it develops.

During an educational session at the WVC Annual Conference on Tuesday, Royal Canin defined the solution, Renal Support Early Consult, as "an early intervention method." The diet complements Antech's testing capabilities, resulting in a well-rounded and proactive strategy for feline CKD owners.

"Being able to predict disease enables for a novel feline CKD care pathway that offers an improved standard of care," said Todd East, DVM, Royal Canin's director of veterinary affairs. "This new path includes increased engagement between veterinarians, pet owners, and pets through more frequent veterinary visits, the ability to track kidney values over time, and, most recently, a specialised diet formulated specifically for early CKD and available from Royal Canin by veterinary authorization. We believe that cats and their owners will have a better future."

Renal Support Early Consult is a high-calorie, high-nutrient formula that supports healthy renal function by stimulating hunger, managing phosphorus levels, delivering specific antioxidants and fatty acids from fish oil, and providing targeted protein levels.

"RenalTech is having an enormously positive impact on how veterinarians manage chronic renal disease in cats—and how pet owners want to treat it," Jennifer Ogeer, DVM, Antech's vice president of medical science and innovation, stated. "We urgently want new early care strategies now that veterinarians can forecast the beginning of disease up to two years in advance. Nutritional adjustments are one of the most effective techniques, and Antech and Royal Canin's approach is specifically created to provide veterinarians with an exceptional opportunity to help cats with disease have the best possible outcome."

RenalTech was first introduced by Antech in October of this year. The solution employs artificial intelligence and veterinarian information to reliably forecast CKD in cats, which is the primary cause of mortality in cats over the age of five years and affects up to 40% of cats over the age of ten.

Jennifer Lopez, DVM, with Antech, and Adrienne Bautista, DVM, Ph.D., with Royal Canin, presented on the nutritional solution the WVC Conference. Those who attended the WVC Annual Conference can access an on-demand recording of the presentation, titled "CKD, You Don't Know Me: Prediction, Diagnosis and Nutritional Management in partnership with Royal Canin.”

Read more about  product development, ingredients and formulation .

Source link